"Formed in 2005, CLS Health (formerly Clear Lake Specialties) has grown to over 90 plus providers with a mission to provide outstanding medical care to Clear Lake and surrounding areas. The physician-owned multi-specialty group includes 10 locations in Houston and partners with local healthcare institutions to deliver exceptional medical care to our patients in Baytown, Friendswood, Webster, Pasadena, League City, and surrounding areas. For over 15 years, CLS Health has been a leader in comprehensive inpatient and outpatient care. The company's rebrand reflects its continued leadership in an ever-evolving industry."

During the past decade, Clear Lake Specialties conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clear Lake Specialties" #1 sponsor was "Horizon Therapeutics Ireland DAC" with 2 trials, followed by "Abbott Nutrition" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Goldfinch Bio, Inc." with 1 trials sponsored and "H. Lundbeck A/S" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clear Lake Specialties" #1 collaborator was "ClinLogix. LLC" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Clear Lake Specialties" are "Benign Prostatic Hyperplasia" (1 trials), "Diabetes Complications" (1 trials), "Diabetes Mellitus" (1 trials), "Diabetic Nephropathies" (1 trials) and "Endocrine System Diseases" (1 trials). Many other conditions were trialed in "Clear Lake Specialties" in a lesser frequency.

Most popular intervention types in "Clear Lake Specialties" are "Drug" (6 trials), "Biological" (2 trials), "Device" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pegloticase" (2 trials), "Placebo" (2 trials), "Baricitinib" (1 trials), "Droxidopa capsules" (1 trials) and "Fostamatinib 150 mg bid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clear Lake Specialties" are 8 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clear Lake Specialties". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Clear Lake Specialties, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clear Lake Specialties, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".